• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,359.41 74.34
( 0.09%)
Global Indices
Nasdaq
53,071.47 150.40
(0.28%)
Dow Jones
7,557.54 53.30
(0.71%)
Hang Seng
69,576.15 -167.92
(-0.24%)
Nikkei 225
10,649.07 -29.96
(-0.28%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
38.89
74.73
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Hindustan Unilever consolidated net profit rises 21.43% in the March 2026 quarter
Apr 30,2026
Net profit of Hindustan Unilever rose 21.43% to Rs 2992.00 crore in the quarter ended March 2026 as against Rs 2464.00 crore during the previous quarter ended March 2025. Sales rose 8.15% to Rs 16207.00 crore in the quarter ended March 2026 as against Rs 14985.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 41.23% to Rs 15040.00 crore in the year ended March 2026 as against Rs 10649.00 crore during the previous year ended March 2025. Sales rose 5.27% to Rs 63763.00 crore in the year ended March 2026 as against Rs 60573.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales16207.0014985.00 8 63763.0060573.00 5
OPM %23.6724.14 -23.5924.26 -
PBDT4025.003850.00 5 15380.0015334.00 0
PBT3677.003532.00 4 14047.0014081.00 0
NP2992.002464.00 21 15040.0010649.00 41